Cytokinetics, Inc. (CYTK)
56.16
-2.37
(-4.05%)
USD |
NASDAQ |
Nov 12, 16:00
56.16
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Market Cap : 7.819B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 7.819B |
| November 11, 2026 | 8.149B |
| November 10, 2026 | 7.821B |
| November 09, 2026 | 7.677B |
| November 06, 2026 | 7.475B |
| November 05, 2026 | 7.734B |
| November 04, 2026 | 8.854B |
| November 03, 2026 | 8.675B |
| November 02, 2026 | 8.636B |
| October 30, 2026 | 8.741B |
| October 29, 2026 | 8.785B |
| October 28, 2026 | 8.503B |
| October 27, 2026 | 8.537B |
| October 26, 2026 | 8.427B |
| October 23, 2026 | 8.496B |
| October 22, 2026 | 8.649B |
| October 21, 2026 | 8.723B |
| October 20, 2026 | 8.874B |
| October 19, 2026 | 8.693B |
| October 16, 2026 | 8.596B |
| October 15, 2026 | 8.870B |
| October 14, 2026 | 8.802B |
| October 13, 2026 | 8.551B |
| October 12, 2026 | 8.713B |
| October 09, 2026 | 8.730B |
| Date | Value |
|---|---|
| October 08, 2026 | 8.605B |
| October 07, 2026 | 8.481B |
| October 06, 2026 | 8.513B |
| October 05, 2026 | 8.700B |
| October 02, 2026 | 9.103B |
| October 01, 2026 | 9.106B |
| September 30, 2026 | 9.146B |
| September 29, 2026 | 9.108B |
| September 28, 2026 | 9.180B |
| September 25, 2026 | 8.972B |
| September 24, 2026 | 9.111B |
| September 23, 2026 | 9.132B |
| September 22, 2026 | 9.379B |
| September 21, 2026 | 9.375B |
| September 18, 2026 | 9.544B |
| September 17, 2026 | 9.702B |
| September 16, 2026 | 9.629B |
| September 15, 2026 | 9.618B |
| September 14, 2026 | 10.05B |
| September 11, 2026 | 10.24B |
| September 10, 2026 | 10.22B |
| September 09, 2026 | 10.28B |
| September 08, 2026 | 10.46B |
| September 04, 2026 | 10.09B |
| September 03, 2026 | 10.26B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BridgeBio Pharma, Inc. | 15.32B |
| Alnylam Pharmaceuticals, Inc. | 20.97B |
| BioMarin Pharmaceutical, Inc. | 10.98B |
| Exelixis, Inc. | 17.09B |
| Ionis Pharmaceuticals, Inc. | 4.545B |
Market Cap Related Metrics
| PS Ratio | 64.05 |
| Price | 56.16 |
| Earnings Yield | -10.75% |